Free Trial
ASX:BOT

Botanix Pharmaceuticals (BOT) Stock Price, News & Analysis

Botanix Pharmaceuticals logo

About Botanix Pharmaceuticals Stock (ASX:BOT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.63 million shs
Average Volume
N/A
Market Capitalization
A$912.82 million
P/E Ratio
N/A
Dividend Yield
2.96%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Botanix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BOT Stock News Headlines

Botanix Pharmaceuticals Limited (BXPHF) - Yahoo Finance
BOT - Botanix Pharmaceuticals Ltd Executives - Morningstar
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
See More Headlines

BOT Stock Analysis - Frequently Asked Questions

Botanix Pharmaceuticals Limited (ASX:BOT) announced its quarterly earnings data on Thursday, February, 28th. The company reported ($0.01) earnings per share for the quarter. Botanix Pharmaceuticals had a negative net margin of 670.20% and a negative trailing twelve-month return on equity of 18.00%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Botanix Pharmaceuticals investors own include Alphabet (GOOG), Meta Platforms (META), Arafura Rare Earths (ARU), Canopy Growth (CGC), Manning & Napier (MN), (STB.TO) (STB) and (YCB) (YCB).

Company Calendar

Last Earnings
2/28/2019
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:BOT
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$13.87 million
Net Margins
-670.20%
Pretax Margin
N/A
Return on Equity
-18.00%
Return on Assets
-12.74%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
22.21
Quick Ratio
1.26

Sales & Book Value

Annual Sales
A$2.07 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.50
Book Value
A$0.07 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,810,000,000
Free Float
N/A
Market Cap
A$912.82 million
Optionable
Not Optionable
Beta
1.71
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (ASX:BOT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners